Drug combinations are widely used in cancer therapy, including for acute myeloid leukaemia, but their mechanisms remain poorly understood. Here, the authors introduce CoPISA, a proteomics method that uncovers combination-specific protein targets and mechanisms beyond classical synergy.
- Elham Gholizadeh
- Ehsan Zangene
- Mohieddin Jafari
